Industry resources and insights

Sort by year

All time
2025
2024
2023
2022
2021
2020
2019 and older

17.03.2025

Protected: Presentation: How to navigate early pay...

There is no excerpt because this is a protected post.

Articles

17.03.2025

PICO and Mix: What the PICO exercises mean for JCA...

The population, intervention, comparator, and outcomes (PICO) element of the upcoming EU Joint Clini...

News

12.03.2025

World EPA 2025 Summary

We were thrilled to attend the World Evidence, Pricing and Access Congress (World EPA) in Amsterdam ...

06.03.2025

How to navigate early payer scientific advice: a B...

Charlie Hewitt from Remap Consulting initiated today’s session by providing a description of the c...

28.02.2025

Unlocking Access: The Role of Patient Engagement i...

AUTHORS: Joyce Atim, Rahul Vadehra Rare diseases have a significant impact on people worldwide...

Artificial Intelligence

26.02.2025

World EPA 2025: Evaluating the capabilities of AI ...

AUTHORS: Ella Odams, Richard Sloggett, Graham Foxon OBJECTIVES To evaluate if ChatGPT is a rel...

Load more

Browse by topic

Biosimilars
Devices & Diagnostics
Digital Health
Early Access
Early Payer Dialogue
Emerging & Developing Markets
Funding
Gene Therapy & ATMPs
HTA
International Reference Pricing
Launch
Managed Entry Agreements
Medicine manufacturing
NICE
Oncology
Orphan Drugs
PMA Trends
Pricing
Rare Diseases
Real World Evidence
Team Remap
Tendering & Procurement
Training

Content type

All
Articles
Artificial Intelligence
Case Studies
China
Digital Health
Insider Insights
News
Pricing
Publications
Webinar

Subscribe